Related Experiment Video

Updated: Jun 6, 2026

Derivation and Characterization of a Transgene-free Human Induced Pluripotent Stem Cell Line and Conversion into Defined Clinical-grade Conditions
10:48

Derivation and Characterization of a Transgene-free Human Induced Pluripotent Stem Cell Line and Conversion into Defined Clinical-grade Conditions

Published on: November 26, 2014

Spontaneous and therapy-induced immunity to pluripotency genes in humans: clinical implications, opportunities and

Madhav V Dhodapkar1, Kavita M Dhodapkar

  • 1Section of Hematology, Yale University, New Haven, CT 06510, USA. madhav.dhodapkar@yale.edu

Cancer Immunology, Immunotherapy : CII
|November 25, 2010
PubMed

Insights

The human immune system can target key pluripotency genes, which are also involved in cancer. This immune response is observed in patients undergoing chemotherapy for germ cell tumors, impacting cancer treatment and stem cell therapies.

Area of Science:

  • Immunology
  • Developmental Biology
  • Oncology
  • Stem Cell Biology

Background:

  • Embryonal stem cells (ESCs) possess pluripotency pathways that share similarities with oncogenesis.
  • The human immune system's role in recognizing and targeting cancer cells is well-established.
  • Understanding immune interactions with ESC-related pathways could offer new therapeutic strategies.

Purpose of the Study:

  • To explore the human immune system's capacity to target key genes associated with pluripotency.
  • To investigate the induction of immunity against pluripotency genes in cancer patients.
  • To discuss the implications of targeting stemness pathways for cancer therapy and regenerative medicine.

Main Methods:

  • Review of recent studies on pluripotency pathways and oncogenesis.
  • Analysis of immune responses in patients with germ cell tumors undergoing chemotherapy.
  • Discussion of immunologic targeting of stemness-related pathways.

Main Results:

  • Evidence suggests the human immune system can target specific pluripotency-associated genes.
  • Immunity against these genes is induced in patients with germ cell tumors following chemotherapy.
  • Chemotherapy-induced cell death in germ cell tumors can trigger an immune response against stemness pathways.

Conclusions:

  • The immune system's ability to target pluripotency genes has significant implications for cancer treatment.
  • Targeting stemness pathways immunologically may offer novel approaches for cancer immune regulation.
  • Understanding these immune responses is crucial for developing safe and effective regenerative therapies using ESCs.

More Related Videos

Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions09:34

Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions

Published on: November 27, 2017

In vivo Reprogramming of Adult Somatic Cells to Pluripotency by Overexpression of Yamanaka Factors12:12

In vivo Reprogramming of Adult Somatic Cells to Pluripotency by Overexpression of Yamanaka Factors

Published on: December 17, 2013

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Maintenance of the ES Cell State01:14

Maintenance of the ES Cell State

The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...